Neurophet Inc (380550)

Currency in KRW
21,000
-1,000(-4.55%)
Closed·
380550 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
21,00021,950
52 wk Range
10,15036,700
Key Statistics
Bid/Ask
21,000.00 / 21,050.00
Prev. Close
22,000
Open
21,950
Day's Range
21,000-21,950
52 wk Range
10,150-36,700
Volume
237.39K
Average Volume (3m)
878K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
380550 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Health Care Technology industry

Neurophet Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Neurophet, Inc., operates as a neuroscience company, engages in the development of medical artificial intelligence solutions in the field of brain science and diseases. The company offers Neurophet AQUA, AI-powered diagnosis assistant software for brain diseases; Neurophet SCALE PET, a software that quantitatively analyzes biomarkers targeted by a specific radiotracer using PET; Neurophet tES LAB, AI-Powered software to generate a 3D model using brain MRI and simulate electrical stimulation for treatment planning; and Neurophet innk, a non-invasive electrical stimulation device designed to aid in the functional recovery and rehabilitation of patients with brain diseases. It also provides Consulting services for design systems and quality management systems. The company was founded in 2016 and is headquartered in Seoul, South Korea.

Compare 380550 to Peers and Sector

Metrics to compare
380550
Peers
Sector
Relationship
P/E Ratio
−11.9x−0.9x−0.5x
PEG Ratio
−0.27−0.130.00
Price/Book
-1.6x2.6x
Price / LTM Sales
101.7x4.2x3.2x
Upside (Analyst Target)
-126.2%47.4%
Fair Value Upside
Unlock15.1%6.9%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
20/03/2026
EPS / Forecast
-- / --
Revenue / Forecast
7B / --
EPS Revisions
Last 90 days

FAQ

What Is the Neurophet (KOSDAQ: 380550) Share Price Today?

The Neurophet stock price today is 21,000 KRW.

What Stock Exchange Does Neurophet (380550) Trade On?

Neurophet is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for Neurophet?

The stock symbol (also called a 'ticker') for Neurophet is "380550."

What Is the Current Neurophet Market Capitalisation?

As of today, Neurophet (KOSDAQ: 380550) market cap is 266.02B KRW.

What Is Neurophet's (380550) Earnings Per Share (TTM)?

The Neurophet EPS is currently -2,302 (Trailing Twelve Months).

When Is the Next Neurophet Earnings Date?

Neurophet's next earnings report will be released on 03/06/2026.

Is 380550 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Neurophet moving averages and other technical indicators, the daily buy/sell signal for 380550 stock is Sell.

How Many Times Has Neurophet Stock Split?

Neurophet has split 0 times. (See the 380550 stock split history page for full effective split date and price information.)

What is the current trading status of Neurophet (KOSDAQ: 380550)?

As of 28/04/2026, Neurophet (380550) is trading at a share price of 21,000 KRW, with a previous close of 22,000 KRW. The stock has fluctuated within a day range of 21,000 KRW to 21,950 KRW, while its 52-week range spans from 10,150 KRW to 36,700 KRW.

Industry Spotlight

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.